Nanogen, Inc. , developer of advanced diagnostic products, announced today that Heiner Dreismann, Ph.D. has been named to its Board of Directors.

EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases,

EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns, President and Chief Executive Officer,

Advanced Life Sciences Holdings, Inc. today announced that it will present at the Rodman & Renshaw Healthcare Conference which will be webcast live via streaming audio. Advanced Life Sciences’ management will provide an overview and update of the Company’s business.

Every 21 minutes a child is diagnosed with autism, the fastest growing disability in the U.S. and Canada. Autism affects the development of a child’s social and communication skills and requires immediate and highly customized

Sigma-Aldrich , a $1.7 billion Life Science and High Technology company, announced the release of the Universal Proteomics Standard during the HUPO Protein Test Sample Standards/NIST Workshop, an educational session prior to the HUPO 5th Annual World Congress. The standard, a complex mixture of 48 human proteins,

Cambrex Corporation  announced today that the previously disclosed sale of its Human Health facilities in Cork, Ireland, and Landen, Belgium, to International Chemical Investors S.A. II (ICIG) of Luxembourg had been completed on October 27, 2006.